Nonorgan specific autoantibodies and heart damage

Area of Science:

• Cardiology
• Immunology
• Rheumatology

Background:

• Autoantibodies can mediate heart damage affecting valves, arteries, and conduction tissue.
• Verrucous endocarditis is common in antiphospholipid syndrome (APS), often with central nervous system involvement.
• Antiphospholipid antibodies (aPL) deposit at the subendothelial level of affected heart valves.

Purpose of the Study:

• To explore the role of various autoantibodies in heart damage.
• To investigate the association between specific autoantibodies and atherosclerosis in autoimmune diseases.
• To understand the pathogenic role of anti-Ro/SS-A antibodies in congenital heart block.

Main Methods:

• Review of existing literature on autoantibodies and cardiac manifestations.
• Analysis of experimental models (in vitro and in vivo) for aPL, anti-oxLDL, anti-HSP65, and AECA.
• Examination of clinical observations linking autoantibodies to atherosclerosis and congenital heart block.

Main Results:

• aPL, anti-oxLDL, anti-HSP65, and AECA are implicated in atherosclerosis pathogenesis in systemic autoimmune diseases and vasculitis.
• The association of these antibodies with clinical/subclinical atherosclerosis in patients remains controversial.
• Anti-Ro/SS-A antibodies are central to the pathogenesis of congenital heart block in offspring of affected mothers.

Conclusions:

• Autoantibodies are significant mediators of diverse heart pathologies, including endocarditis and atherosclerosis.
• Further research is needed to clarify the controversial links between specific autoantibodies and atherosclerosis.
• Anti-Ro/SS-A antibodies are critical in the development of congenital heart block, highlighting a specific autoimmune mechanism affecting cardiac conduction.